Increased atrial fibrillation mortality: United States, 1980-1998 - PubMed (original) (raw)
. 2002 May 1;155(9):819-26.
doi: 10.1093/aje/155.9.819.
Affiliations
- PMID: 11978585
- DOI: 10.1093/aje/155.9.819
Increased atrial fibrillation mortality: United States, 1980-1998
Wendy A Wattigney et al. Am J Epidemiol. 2002.
Abstract
The authors used death certificate data to evaluate national trends in the reporting of atrial fibrillation as an underlying or contributory cause of death for groups defined by age (45 years or older), sex, and race (Black vs. White) and to examine comorbidity. The multiple-causes mortality files from 1980 through 1998 were analyzed for decedents, with atrial fibrillation (International Classification of Diseases, Ninth Revision, code 427.3) listed as one of up to 20 conditions causing death. The number of decedents with atrial fibrillation increased from 18,947 in 1980 to 61,946 in 1998, and the proportion with atrial fibrillation reported as the underlying cause of death rose from 8.3% in 1980 to 11.6% in 1998. Age-standardized death rates from 1980 to 1998 were consistently highest among White men, followed (in descending order) by White women, Black men, and Black women. Overall, the age-standardized rate (per 100,000) increased from 27.6 in 1980 to 69.8 in 1998 (an average annual increase of 5.4%, p < 0.0001). Ischemic heart disease was the most frequent underlying cause of death among decedents with atrial fibrillation (26.8%). These findings emphasize the need for increased application of proven prevention and control measures to decrease associated cardiovascular morbidity and mortality.
Similar articles
- Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018.
Tanaka Y, Shah NS, Passman R, Greenland P, Lloyd-Jones DM, Khan SS. Tanaka Y, et al. J Am Heart Assoc. 2021 Aug 3;10(15):e020163. doi: 10.1161/JAHA.120.020163. Epub 2021 Jul 29. J Am Heart Assoc. 2021. PMID: 34320819 Free PMC article. - Early-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortality.
Patton KK, Benjamin EJ, Kosheleva A, Curtis LH, Glymour MM. Patton KK, et al. Ann Epidemiol. 2011 Oct;21(10):732-8. doi: 10.1016/j.annepidem.2011.06.003. Epub 2011 Jul 27. Ann Epidemiol. 2011. PMID: 21798760 Free PMC article. - Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years - United States, 1968-2015.
Van Dyke M, Greer S, Odom E, Schieb L, Vaughan A, Kramer M, Casper M. Van Dyke M, et al. MMWR Surveill Summ. 2018 Mar 30;67(5):1-11. doi: 10.15585/mmwr.ss6705a1. MMWR Surveill Summ. 2018. PMID: 29596406 Free PMC article. - Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults.
Howard G, Safford MM, Moy CS, Howard VJ, Kleindorfer DO, Unverzagt FW, Soliman EZ, Flaherty ML, McClure LA, Lackland DT, Wadley VG, Pulley L, Cushman M. Howard G, et al. J Am Geriatr Soc. 2017 Jan;65(1):83-90. doi: 10.1111/jgs.14472. Epub 2016 Sep 26. J Am Geriatr Soc. 2017. PMID: 27666895 Free PMC article.
Cited by
- Sex-Differences in Atrial Fibrillation Patients: Bias or Proper Management?
Israeli A, Gal D, Younis A, Ehrenberg S, Rozner E, Turgeman Y, Naami E, Naami R, Koren O. Israeli A, et al. Vasc Health Risk Manag. 2022 May 5;18:347-358. doi: 10.2147/VHRM.S366285. eCollection 2022. Vasc Health Risk Manag. 2022. PMID: 35546968 Free PMC article. - Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
Shen AY, Chen W, Yao JF, Brar SS, Wang X, Go AS. Shen AY, et al. CNS Drugs. 2008;22(10):815-25. doi: 10.2165/00023210-200822100-00003. CNS Drugs. 2008. PMID: 18788834 - Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.
Johnson DL, Day JD, Mahapatra S, Bunch TJ. Johnson DL, et al. J Atr Fibrillation. 2012 Feb 2;4(5):477. doi: 10.4022/jafib.477. eCollection 2012 Feb-Mar. J Atr Fibrillation. 2012. PMID: 28496718 Free PMC article. Review. - Atrial septopulmonary bundle of the posterior left atrium provides a substrate for atrial fibrillation initiation in a model of vagally mediated pulmonary vein tachycardia of the structurally normal heart.
Klos M, Calvo D, Yamazaki M, Zlochiver S, Mironov S, Cabrera JA, Sanchez-Quintana D, Jalife J, Berenfeld O, Kalifa J. Klos M, et al. Circ Arrhythm Electrophysiol. 2008 Aug;1(3):175-83. doi: 10.1161/CIRCEP.107.760447. Circ Arrhythm Electrophysiol. 2008. PMID: 19609369 Free PMC article. - A comprehensive view of sex-specific issues related to cardiovascular disease.
Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V. Pilote L, et al. CMAJ. 2007 Mar 13;176(6):S1-44. doi: 10.1503/cmaj.051455. CMAJ. 2007. PMID: 17353516 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical